DAPK2 and neoplasm: In particular, survivorship analysis of early LUAD tumor regression candidates at the stage 1–2 interface (e.g., DAPK2 and PLAC9) revealed these genes to serve as positive LUAD prognosis markers (Figure 5A,D).